Pacira BioSciences Remains A 'Buy' For Pain Management With The NOPAIN Act

Core Insights - Pacira BioSciences, Inc. (NASDAQ: PCRX) is a specialty pharmaceutical company focused on non-opioid pain management therapies, with key products including Exparel, Zilretta, and iovera [1] Group 1 - The NOPAIN Act is expected to provide a favorable secular tailwind for Pacira BioSciences, enhancing the market for non-opioid pain management solutions [1]